Is cytology sample from endobronquial ultrasound (EBUS)-guided transbronchial needle aspiration (TBNA) sufficient for analysis of major known driver mutations in non-small cell lung cancer (NSCLC)?

Authors :: Eva Castellà
Jose Luis Ramirez
Mariona Llatjós
Juan Ruiz Manzano
Montserrat Tierno
Ana Munoz
Erika Mijangos
Enric Carcereny
Monica Botia
Itziar de Aguirre
Cristina Queralt
Felipe Andreo
Anna Estival
Pere Serra
Teresa Moran
Carmen Centeno
Rafael Rosell
Laia Vilà
Maria de los Llanos Gil
Ana Montañes
Source :: Journal of Clinical Oncology. 32:e22110-e22110
Publication Year :: 2014
Publisher :: American Society of Clinical Oncology (ASCO), 2014.
Abstract: e22110 Background: Identification of distinct oncogenic driver mutations is routinely used to guide clinical care in NSCLC patients (p). Tumor tissue availability is one of the major challenges for...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
Ultrasound
Cytology sample
non-small cell lung cancer (NSCLC)
medicine.disease
Tumor tissue
Internal medicine
Medicine
Clinical care
business

Tools